Ratio Examination: TG Therapeutics Inc (TGTX)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

In the latest session, TG Therapeutics Inc (NASDAQ: TGTX) closed at $37.68 down -13.26% from its previous closing price of $43.44. In other words, the price has decreased by -$13.26 from its previous closing price. On the day, 12.2 million shares were traded.

Ratios:

For a deeper understanding of TG Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.03 and its Current Ratio is at 6.25. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.

On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A sold 11,337 shares for $30.29 per share. The transaction valued at 343,443 led to the insider holds 670,632 shares of the business.

Power Sean A sold 10,021 shares of TGTX for $285,939 on Jan 06 ’25. The CFO now owns 660,611 shares after completing the transaction at $28.53 per share. On Jan 06 ’25, another insider, Power Sean A, who serves as the Officer of the company, bought 10,021 shares for $28.53 each.

Valuation Measures:

As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 154.43, and their Forward P/E ratio for the next fiscal year is 21.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.48 while its Price-to-Book (P/B) ratio in mrq is 26.41.

Stock Price History:

Over the past 52 weeks, TGTX has reached a high of $46.48, while it has fallen to a 52-week low of $15.16. The 50-Day Moving Average of the stock is -1.59%, while the 200-Day Moving Average is calculated to be 26.57%.

Shares Statistics:

A total of 158.78M shares are outstanding, with a floating share count of 142.96M. Insiders hold about 9.96% of the company’s shares, while institutions hold 61.41% stake in the company.

Most Popular